Penumbra Coil 400 4006C0305Recalls & reported problems
Penumbra, Inc. · PC400 Cplx XSft, 3x5 · Class 2 · Implant
All models of Penumbra Coil 400 (120)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI M4244006C03050), received between Oct 30, 2015 and Feb 26, 2018 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Detachment Of Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Detachment Of Device Component1
- Physical Resistance1
Patient problems
- No Consequences Or Impact To Patient1
- Vascular Dissection1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 26, 2018Detachment Of Device Component; Physical Resistance; Detachment Of Device Component; Physical Resistance
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE TO TREAT A BLEEDING ANEURYSM IN THE POSTERIOR COMMUNICATING ARTERY (PCOMM), USING PENUMBRA COIL 400S (PC400S) AND A PX SLIM DELIVERY MICROCATHETER (PX SLIM). DURING THE PROCEDURE, THE PHYSICIAN SUCCESSFULLY DEPLOYED AND DETACHED MULTIPLE PC400S IN THE TARGET VESSEL USING THE PX SLIM. WHILE ADVANCING AND WITHDRAWING ANOTHER PC400 COIL THROUGH THE PX SLIM, THE PHYSICIAN EXPERIENCED RESISTANCE AND THE PC400 UNINTENTIONALLY DETACHED WITHIN THE PX SLIM; HOWEVER, THE PHYSICIAN WAS ABLE TO PUSH AND SUCCESSFULLY PLACE THE DETACHED PC400 IN THE TARGET VESSEL. NEXT, THE PHYSICIAN ATTEMPTED TO PLACE ANOTHER PC400 IN THE TARGET VESSEL. HOWEVER, WHILE ADVANCING AND WITHDRAWING THE PC400, THE PHYSICIAN EXPERIENCED RESISTANCE AGAIN AND THE PC400 UNINTENTIONALLY DETACHED WITHIN THE PX SLIM. WHEN ATTEMPTING TO MANEUVER THE DETACHED PC400, THE PUSHER ASSEMBLY OF THE PC400 PERFORATED THE PX SLIM. THEREFORE, THE PX SLIM WAS REMOVED WITH THE DETACHED PC400 AND THE PUSHER ASSEMBLY INSIDE, AS THE PHYSICIAN ASPIRATED THROUGH THE PX SLIM. THE PROCEDURE ENDED AT THIS POINT. IT WAS REPORTED THAT THE PHYSICIAN NEEDED TO APPLY FORCE WHILE PLACING THE PC4
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7298093 ↗InjuryOct 30, 2015Adverse Event Without Identified Device or Use Problem
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE BASILAR ARTERY USING PENUMBRA COIL 400 COILS (PC400 COILS). IT WAS NOTED THAT THE CERVICAL PORTION OF THE DOMINANT RIGHT VERTEBRAL ARTERY WAS SEVERELY TORTUOUS, ESPECIALLY IN THE V2 SEGMENT AT THE C4-C6 LEVEL. IN ADDITION, THE CERVICAL PORTION OF THE RIGHT INTERNAL CAROTID ARTERY (ICA) WAS MILDLY TORTUOUS AND NON-FLOW-LIMITING STENOSIS WAS VISUALIZED AT THE ORIGIN OF THE RIGHT EXTERNAL CAROTID ARTERY (ECA). DURING THE PROCEDURE, FOUR PC400 COILS WERE DELIVERED INTO THE ANEURYSM FOLLOWING PLACEMENT OF ANOTHER MANUFACTURERS' DEVICES. AFTER PLACEMENT OF THE OTHER MANUFACTURER'S DEVICE, THERE WAS NO EVIDENCE OF PARENT VESSEL INJURY, ARTERIAL DISSECTION OR DISTAL EMBOLIC EVENTS. HOWEVER, UPON REMOVAL OF THE GUIDE CATHETER, IMAGING OF THE RIGHT CERVICAL ARTERY SHOWED AN IATROGENIC DISSECTION WITHIN THE MID V2 SEGMENT AT THE LOCATION OF THE SEVERE TORTUOSITY. THE PHYSICIAN ADDRESSED THE DISSECTION BY USING ANOTHER MANUFACTURER'S DEVICE. ON POST-OPERATIVE DAY 2, THE PATIENT WAS CLINICALLY STABLE AND DISCHARGED TO AN EXTENDED CARE FACILITY. THE INVESTIGATOR ADJUDICATED THE DISSECTION TO BE OF UNCERTAIN RELATIONSHIP TO THE PC400
Patient problems: Vascular Dissection
MAUDE report 5193023 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page